Journal of Tissue Repair and Regeneration · JTRR
Editorial board
The people this journal's published record is answerable to. Every member the journal publishes is listed on this page, with the affiliation, country and research interests held in the journal's own record, and a profile you can open for each one.
12 members 10 countries 7 with a published ORCID iD ISSN 2640-6403
What the board is responsible for
Editorial responsibility is shared across the board and exercised per manuscript, not collectively. A submission is handled by the editor whose expertise fits it.
- Assessing scope
- Deciding whether a manuscript contributes to tissue repair or regeneration, which is settled ahead of and separately from the assessment of its quality. The aims and scope sets out what that means.
- Overseeing expert review
- Selecting reviewers with relevant expertise and weighing what they report. All submissions undergo initial editorial screening. Manuscripts that meet the journal's scope and minimum requirements proceed to independent peer review. Single-blind by default; double-blind review is available on request. Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts.
- Managing competing interests
- Declaring competing interests and standing aside where one exists. Editors recuse themselves from decisions on their own submissions, and those manuscripts are handled independently.
- Acting on research-integrity concerns
- Escalating concerns about a submitted or published article through the journal's editorial policies, including correction and retraction where the record requires it.
- Deciding independently
- Editorial decisions are based on scope, scientific quality, methodological rigor, ethical compliance, reporting quality, and relevance to the journal. They remain independent of fees, membership and editorial or reviewing roles.
The board
All 12 published members, listed in the journal's own order. Each portrait and each name opens that member's profile.
-
Editor-in-Chief
Lin YeLecturer, UHW Main Building.
Research statement on record
- My research interest is to investigate the cancer cells orientated cross-talks with the extracellular matrix (ECM) and stroma cells during the cancer development, progression and metastases
- The first group of molecules of my interest is bone morphogenetic proteins and their signalling
- BMPs play diverse and critical roles in a vicious cycle between cancer cells and the local environment in both primary and secondary tumours, and also contribute to the tumour-associated angiogenesis
- Following my PhD study of bone morphogenetic proteins (BMP) and their signalling in prostate cancer, I continue to explore the mechanism(s) of bone metastasis from prostate cancer and breast cancer, seek and develop therapeutic approach particularly by targeting BMPs signalling
- The second group of molecules which we focus are anthrax toxin receptor 1 (ANTXR1, also known as tumour endothelial marker 8, TEM-8) and anthrax toxin receptor 2 (ANTXR2, also known as capillary morphogenesis gene 2, CMG2)
- These two molecules are initially identified as markers or genes for the angiogenesis
- Our recent studies have shown that aberrant expression and function of these two molecules in the disease progression of breast cancer and prostate cancer
- As these two transmembrane proteins play an important role mediating adhesion and migration of cancer cells upon ECM, and also orchestrating the consequent interactions between cancer cells and micro-environment to enable tumour growth and dissemination
-
Editorial Board
Costica AlomanAssociate Professor, Rush Medical College of Rush University, Chicago, IL
Research interests on record
- Dendritic cell biology (development, function)
- Liver fibrosis biology (immune modulation)
- Autoimmunity
- Immune tolerance and rejection after solid organ transplants
- IL15 signaling
-
Editorial Board
Ilaria BaldelliUniversity of Genoa, Italy
Research interests on record
ADSCs, PRP, lichen sclerosus, wound, radiodermatitis treatment, breast surgery
-
Editorial Board
Miguel Batista JuniorUniversity of Mogi das Cruzes.
Research interests on record
- Adipose tissue biology
- Tissue remodeling
- Inflammation
- Cancer cachexia
- Aging
-
Editorial Board
Richard BrightResearch Fellow, Flinders University, Adelaide, South Australia
Research interests on record
Biomaterials and surface engineering; nanomedicine; antibacterial coatings and wound healing; biomaterial-immune interactions and osteogenesis.
-
Editorial Board
Walid RachidiVice Dean, Université Grenoble Alpes, Saint-Martin-d'Heres, Rhône-Alpes
Research interests on record
Stem cells, Skin engineering, 3D models, Bioprinting, Keratinocytes
-
Editorial Board
Adam Abdul GafoorAdam Science Technology and Research International
Research interests on record
Tissue Repair & Regeneration
-
Editorial Board
Artemis StamboulisThe University of Birmingham, Birmingham
Research interests on record
Development of dental materials (glass ionomer cements), characterisation of biomaterials (polymers, ceramics, composites), 3D printing, antimicrobial surfaces
-
Editorial Board
Xiao-Jun YangProfessor, The Tenth Affiliated Hospital, Southern Medical University (Dongguan People’s Hospital), Dongguan, Guangdong
Research interests on record
Proficient in vaginal surgery, laparoscopic surgery, hysteroscopic surgery for various benign, precancerous and malignant gynecologic diseases, pelvic organ prolapse.
-
Editorial Board
Jun-ichi KiraProfessor, Kyushu University, FUKUOKA-SHI
Research interests on record
- Neuroimmunological research on multiple sclerosis
- Cell biological research on motor neuron diseases
-
Editorial Board
WEI LINIH/NCI/CIP/LEI
Research interests on record
- antibody engineering
- vaccine development
- cancer immunotherapy
-
Editorial Board
Ki-Chul HwangCatholic Kwandong university
Research interests on record
stem cell, microRNA, cardiovascular disease
Affiliations, roles and research interests are shown as the journal's editorial record holds them. To propose a correction to an entry, or to be considered for the board, contact [email protected].